TriSalus Life Sciences, Inc.
TLSI
$4.76
$0.030.63%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -696.95% | 115.78% | 9.79% | -30.44% | 20.12% |
| Total Depreciation and Amortization | 0.74% | 7.14% | -22.70% | -1.21% | -4.07% |
| Total Amortization of Deferred Charges | 13.51% | 4.96% | 2.55% | 7.00% | 9.36% |
| Total Other Non-Cash Items | 112.53% | -218.33% | 72.81% | 121.15% | -50.03% |
| Change in Net Operating Assets | -947.97% | 155.85% | -122.20% | 271.97% | -186.80% |
| Cash from Operations | -56.31% | -160.87% | 33.03% | 49.33% | -62.70% |
| Capital Expenditure | 41.84% | -243.90% | 81.02% | -332.26% | 112.33% |
| Sale of Property, Plant, and Equipment | -- | -- | -100.00% | -- | -100.00% |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 41.84% | -243.90% | 76.70% | -289.25% | 113.03% |
| Total Debt Issued | -- | -- | -- | -- | -100.00% |
| Total Debt Repaid | -100.00% | -200.00% | 50.00% | -500.00% | 98.59% |
| Issuance of Common Stock | -99.33% | 15,134.64% | 218.18% | -99.58% | 7,325.81% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -22.81% | -- | -- | -- | 100.00% |
| Cash from Financing | -100.13% | 15,201.44% | 237.80% | -99.60% | 113.84% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -128.70% | 1,690.93% | 40.89% | -128.19% | 201.45% |